Brief: Theseus Pharmaceuticals reports Q2 results
11/08/2022 12:07
Aug 11 (Reuters) - Theseus Pharmaceuticals Inc THRX.O :
* THESEUS PHARMACEUTICALS ANNOUNCES BUSINESS AND PIPELINE
HIGHLIGHTS AND REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS
* THESEUS PHARMACEUTICALS INC - $228.6 MILLION IN CASH, CASH
EQUIVALENTS, AND INVESTMENTS AS OF JUNE 30, 2022; EXPECTED TO
FUND OPERATIONS INTO Q4 OF 2024
* THESEUS PHARMACEUTICALS INC - NET LOSS WAS $11.6 MILLION
FOR Q2
OF 2022, AS COMPARED TO A NET LOSS OF $6.8 MILLION FOR SAME
PERIOD IN 2021
Source text for Eikon: ID:nPn54v8FSa
Further company coverage: THRX.O
Recent news on Theseus Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Cidara Therapeutics, Senti Bio, Lumentum Holdings
U.S. STOCKS ON THE MOVE-Newmont Corp, Ansys, Karuna Therapeutics
Theseus Pharma rises as Concentra Biosciences agrees to take it private
Brief: Theseus Pharmaceuticals To Be Acquired by Concentra Biosciences
Brief: Theseus Pharmaceuticals Inc Says As Part Of A Reduction In Workforce, Co Terminated Employment Of Timothy P. Clackson, Co's CEO, Effective As Of Dec 7